Supernus Pharma (SUPN) Reports Q4 Revenue of $155M

Go back to Supernus Pharma (SUPN) Reports Q4 Revenue of $155M
SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 47.78 +0.63 (1.34%)
Previous Close $47.15    52 Week High $26.84 
Open $46.70    52 Week Low $9.51 
Day High $47.86    P/E N/A 
Day Low $46.57    EPS $-2.62 
Volume 105,660